Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors.
about
Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicityIn vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K(3) combination.Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapyDNA topoisomerases as targets for anticancer drugs.Potent Anticancer Effects of Bioactive Mushroom Extracts (Phellinus linteus) on a Variety of Human Cancer Cells.Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance.Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway.Superoxide accelerates DNA damage by elevating free-iron levels.Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cellsChanges in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.Generation of reactive oxygen species by human mesothelioma cells.Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis.Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histonesAntineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.Induction of cell death in renal cell carcinoma with combination of D-fraction and vitamin C.Apoptosis deregulation influences chemoresistance to azaguanine in human leukemic cell lines.Generation of reactive oxygen species is not involved in idarubicin-induced apoptosis in human leukaemic cells.Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma.Prevention of mitochondrial injury by manganese superoxide dismutase reveals a primary mechanism for alkaline-induced cell death.Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma.Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin.Protective effect of melatonin against mitomycin C-induced genotoxic damage in peripheral blood of rats.Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs.Hydrogen peroxide induces GADD153 in Jurkat cells through the protein kinase C-dependent pathway.The ATM protein is required for sustained activation of NF-kappaB following DNA damage.P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells.Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.
P2860
Q28379483-80CB95B8-AF91-4DEC-AF29-00E8FAB9613EQ31706395-961C97D3-5648-4C49-A00F-2525E7CB9A81Q33734981-F85E484A-2784-4C97-99BE-EB6C6491FE55Q34448509-C26DC4AF-0C0C-405F-A288-DA33CADAF652Q34575783-77CA38BB-06E5-4734-9D9B-AE616EC1E7B0Q34616111-7B76BEEF-CA49-4743-8183-B1DEBA042677Q35027940-D9EA1C2B-72C5-493A-BCE6-B7345487EE70Q35429931-FB0594DA-8D0D-4DF9-809C-857A834D4F0BQ35920866-E6985D8F-E98E-48AA-AB3C-ABB1ED15FDB0Q35921515-58D7BB26-78A4-4FFE-A8FC-CE1485A3AF7BQ35962446-790A6F92-5419-4CE4-9757-1AF87C4A835CQ35977902-31BA487F-CF1D-46CC-879E-D96E0C401B80Q36620108-473A9A08-3901-41F1-9AB9-5B32D7E75220Q36642278-2877E0D9-63D3-40A3-8CC9-78081FC70A6AQ37008894-1F87310C-737A-43C2-A4FB-4565B691C865Q37202186-D4F3FA0B-9733-4D0C-9A27-9B0910244634Q37448363-4F6EB88A-778F-4738-BDA2-D5B0368DE03BQ39206336-908FC238-47D1-4774-A897-D4DA8B922B51Q39393877-DBC6A101-8E7E-4F6E-9981-03AD460DDCFEQ40751079-64D202B7-A091-4D33-A3ED-48295C7F0423Q40858541-2DB1E12F-E60E-48D6-ADD0-1C2940ADA63FQ41045785-C6E466C0-996E-499B-AA36-BB967F1063E4Q41047702-72799362-8B17-4817-9F95-17402A4BEE28Q41578260-CCDB7989-BFE3-420A-910F-D9951A81A541Q41791273-D4EAEF5A-4C16-4E13-9821-F3D39C1AB289Q44163689-5F4ED024-DEE8-4110-9EAE-3803296D8B97Q45029145-4731F893-D74B-4311-A1A6-9AFBC81F0CA8Q48211878-2A605243-3D3E-4C01-A1D6-C7BBF3DBD33BQ48324019-648FCD57-AA96-4DE5-AB4C-E1BEB4599C61Q54626064-2EC88013-C1E4-4A42-B07F-219EA38083F2Q55055773-B3345A60-14DD-4D8A-81C1-8BB201192075
P2860
Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Free radicals and anticancer d ...... resistance by certain tumors.
@en
Free radicals and anticancer d ...... resistance by certain tumors.
@nl
type
label
Free radicals and anticancer d ...... resistance by certain tumors.
@en
Free radicals and anticancer d ...... resistance by certain tumors.
@nl
prefLabel
Free radicals and anticancer d ...... resistance by certain tumors.
@en
Free radicals and anticancer d ...... resistance by certain tumors.
@nl
P1476
Free radicals and anticancer d ...... resistance by certain tumors.
@en
P2093
P304
P356
10.1016/0891-5849(90)90155-C
P577
1990-01-01T00:00:00Z